CD1C and colorectal cancer: Melanoma, testicular cancer or colorectal cancer cells that were exposed to cisplatin or oxaliplatin could enhance the phagocytosis of CD16+ DCs, CD1c+ DCs, and pDCs and encourage them to gain a mature phenotype (26).